Application 089325
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TESTOSTERONE ENANTHATE | TESTOSTERONE ENANTHATE | Injectable; Injection | 200MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TESTOSTERONE ENANTHATE | TESTOSTERONE ENANTHATE | Eugia US LLC | 82a98132-9d5f-40a5-8c4f-f52f2a5de60e | 2026-06-12 | Warnings, Adverse reactions | TESTOSTERONE ENANTHATE TESTOSTERONE ENANTHATE |
| TESTOSTERONE ENANTHATE | TESTOSTERONE ENANTHATE | Hikma Pharmaceuticals USA Inc. | e89d6458-428c-4256-97a3-f1fa851293c1 | 2026-05-08 | Warnings, Adverse reactions | TESTOSTERONE ENANTHATE TESTOSTERONE ENANTHATE |
| XYOSTED | TESTOSTERONE ENANTHATE | Antares Pharma, Inc. | 8a3d204c-be26-49e0-8599-0ac12a272e81 | 2025-07-01 | Warnings, Adverse reactions | TESTOSTERONE ENANTHATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.